The main reason why the insider enrichment scheme fits most pennies is because there is no real huge revenue and profit potential, I.e. The insiders are better off selling their shares now then waiting until next year because next year will be another year where the business remains stagnant and their shares may be worth less.
TRTC is exactly the opposite: huge revenue and profit potential with 6-8 licenses in the biggest marijuana market in the world with another 6-8 coming in 2016 when NEVADA goes recreational.
Without any other markets, we are talking a bare minimum of $100M in revenues in 2016.
I know it must be hard for many to believe this is possible or this will happen because of previous disappointments on the OTC, but try to leave your biases behind and critically analyze what 6-8 licenses will mean in dollar figures in 2016, and realize this idea that they won't get much better funding now than their previous funding, when they had nothing cannabis-related going on, makes zero sense.
The Dominion PIPE started being negotiated when they were at .06 and had $500,000 in quarterly revenue from EG.
Look at what they have now.
5 acre facility
Oakland Lab
6-8 licenses in Nevada with 1-3 dispensaries in Las Vegas and 1 dispensary in Reno
Prospect of folding BLUM Oaklsnd into TRTC in Q1 2015 is very real
Funding will come from institutions competing with each other to get some TRTC shares and competing with each other to offer the best loan terms.
The insiders' shares will be worth a lot more in 2016 than they are now.
A lot more.
And this is not my opinion.
This is what TRTC management thinks and why they have sold less than 1% of their shares in 3 years.
Open your eyes, drop your biases and think.
And then reread this post and think some more.
TRTC is very real and so am I.
Sleek
